Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Any type of hormonal contraceptive may increase risk of breast cancer

General Research

An analysis of data by researchers at the Nuffield Department of Population Health’s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published in PLOS Medicine.

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

General Research

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

General Research

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

Athena Swan Awards and Appointments General

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

Awards and Appointments General Research

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Events General

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

General Research

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

General Research

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

General Public Engagement with Research Research

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

General Research

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.

Unlocking the secrets of cAMP signalling in the heart: a pathway to targeted therapeutics

General Research

A new Department of Physiology, Anatomy and Genetics study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. Researchers have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.

Key exosome subtype in cancer progression identified

General Research

Collaborative work from Department of Physiology, Anatomy & Genetics (DPAG) and Department of Oncology researchers has revealed a potential new pathway to block the production of a specific group of exosomes made in the cell’s recycling system that can promote the growth of cancerous tumours.

The women founders contributing to Oxford’s spinout success

General Innovation Research

More spinout companies are created by the University of Oxford than any other UK University and an increasing number of their founders and senior leaders are women.

Genetic variants influencing human fertility identified - new research

General Research

How many children an individual may have is influenced by reproductive biology and human behaviour, according to the largest study to date, which identifies genetic determinants. The study, led by researchers at the Universities of Cambridge, Oxford and Pennsylvania, also identified that the human genome has been influenced by natural selection for thousands of years and continues to affect fertility today.

Diagnosing endometriosis without surgery

General Research

Tatjana Gibbons, a DPhil student at Oxford’s Nuffield Department of Women's & Reproductive Health, talks about research to develop a new 20-minute diagnostic test for endometriosis.

How signals from your body could be making you anxious

General Research

Where do emotions come from? This is a question that has interested scientists for centuries.

Oxford researcher deployed with UK medical team to support Turkey following major earthquake


Alessandra Morelli, a research midwife for the UK Midwifery Study System (UKMidSS) based in Nuffield Department of Population Health’s National Perinatal Epidemiology Unit, has been deployed as a Data Manager with the UK Emergency Medical Team (UK-EMT) to support their mission in Turkey following a major earthquake.

Ensuring LGBTQI+ people are treated fairly in mental health data

General Research

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

NHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds

Coronavirus COVID-19 General

A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.

Study supports evidence ivermectin not effective to treat COVID-19

Coronavirus COVID-19 General

High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.

Load More